Wolfgang Holtz

Prof. Dr. Wolfgang Holtz

orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2008 in Theriogenology
Verified
Journal Article
Closed access
WHWolfgang Holtz
Wolfgang Holtz
BSB. Sohnrey
B. Sohnrey
MGM. Gerland
M. Gerland
MDM.-A. Driancourt
M.-A. Driancourt

1 January 2001 in Journal of Animal Science
Verified
Journal Article
Closed access
PDF file
MEM. El-Gayar
M. El-Gayar
WHWolfgang Holtz
Wolfgang Holtz
The suitability of the open pulled-straw (OPS) method for vitrifying bovine embryos was tested for goat embryos. Of 14 does receiving OPS-vitrified embryos, all became pregnant and 13 (93%) kidded. The corresponding values for an established conventional freezing program were 58% pregnant and 50% (6/12) kidding. Overall embryo survival amounted to 64% (18/28) for OPS-vitrified and 42% (10/24) for conventionally frozen embryos. All differences were statistically significant. It is concluded that OPS vitrification is a suitable method for cryopreserving caprine d-7 blastocysts.

1 July 2005 in Journal of Animal Science
Verified
Journal Article
Closed access
PDF file
BSB. Sohnrey
B. Sohnrey
WHWolfgang Holtz
Wolfgang Holtz
A newly developed technique for transcervical deep uterine insemination of goats is described. An experiment was conducted to compare this transcervical method with the laparoscopic intrauterine insemination using frozen-thawed semen. Of the 46 primiparous and 21 multiparous estrus-synchronized Boer goat does inseminated transcervically, 71% (22/31) kidded compared with 53% (19/36) of does inseminated laparoscopically (P < 0.025). The corresponding litter sizes were 2.27 and 1.89 (P < 0.01). In another 34 parous does inseminated transcervically without preceding hormone treatment, kidding rate and litter size were 71% and 1.76, respectively. We conclude that transcervically conducted bilateral deep cornual insemination may be considered a viable alternative to laparoscopic insemination.

1 July 2012 in Reproduction
Verified
Journal Article
Closed access
PDF file
MSM Saleh
M Saleh
MSM Shahin
M Shahin
WWW Wuttke
W Wuttke
MGM Gauly
M Gauly
WHWolfgang Holtz
Wolfgang Holtz
The present investigation addresses the pharmacokinetics of human chorionic gonadotropin (hCG), intramuscularly (i.m.) administered to goats. Nine pluriparous does of the Boer goat breed, 2–6 years of age and weighing 45–60 kg, were administered 500 IU hCG (2 ml Chorulon) deep into the thigh musculature 18 h after superovulatory FSH treatment. Blood samples were drawn from the jugular vein at 2 h intervals for the first 24 h, at 6 h intervals until 42 h, and at 12 h intervals until 114 h after administration. After centrifugation, plasma hCG concentrations were determined by electrochemiluminescence immunoassay. Pharmacokinetical parameters were as follows: lag time, 0.4 (s.e.m. 0.1) h; absorption rate constant, 0.34 (s.e.m. 0.002) h; absorption half-life, 2.7 (s.e.m. 0.5) h; elimination rate constant, 0.02 (s.e.m. 0.002) h; biological half-life, 39.4 (s.e.m. 5.1) h; and apparent volume of distribution, 16.9 (s.e.m. 4.3) l. The plasma hCG profile was characterized by an absorption phase of 11.6 (s.e.m. 1.8) h and an elimination phase of 70.0 (s.e.m. 9.8) h, with considerable individual variation in bioavailability and pharmacokinetical parameters. Biological half-life was negatively correlated (P<0.05) with peak concentration (r=−0.76), absorption rate constant (r=−0.78), and elimination rate constant (r=−0.87). The results indicate that after rapid absorption, hCG remains in the circulation for an extended period. This has to be taken into account when assessing the stimulatory response to hCG treatment on an ovarian level. Abstract The present investigation addresses the pharmacokinetics of human chorionic gonadotropin (hCG), intramuscularly (i.m.) administered to goats. Nine pluriparous does of the Boer goat breed, 2–6 years of age and weighing 45–60 kg, were administered 500 IU hCG (2 ml Chorulon) deep into the thigh musculature 18 h after superovulatory FSH treatment. Blood samples were drawn from the jugular vein at 2 h intervals for the first 24 h, at 6 h intervals until 42 h, and at 12 h intervals until 114 h after administration. After centrifugation, plasma hCG concentrations were determined by electrochemiluminescence immunoassay. Pharmacokinetical parameters were as follows: lag time, 0.4 (s.e.m. 0.1) h; absorption rate constant, 0.34 (s.e.m. 0.002) h; absorption half-life, 2.7 (s.e.m. 0.5) h; elimination rate constant, 0.02 (s.e.m. 0.002) h; biological half-life, 39.4 (s.e.m. 5.1) h; and apparent volume of distribution, 16.9 (s.e.m. 4.3) l. The plasma hCG profile was characterized by an absorption phase of 11.6 (s.e.m. 1.8) h and an elimination phase of 70.0 (s.e.m. 9.8) h, with considerable individual variation in bioavailability and pharmacokinetical parameters. Biological half-life was negatively correlated (P<0.05) with peak concentration (r=−0.76), absorption rate constant (r=−0.78), and elimination rate constant (r=−0.87). The results indicate that after rapid absorption, hCG remains in the circulation for an extended period. This has to be taken into account when assessing the stimulatory response to hCG treatment on an ovarian level.


15 January 2009 in Theriogenology
Verified
Journal Article
Closed access
XWX.L. Wang
X.L. Wang
MEM. El-Gayar
M. El-Gayar
PKP.G. Knight
P.G. Knight
WHWolfgang Holtz
Wolfgang Holtz